{"id":1209381,"title":"DSEN Abstract: SGLT2 Inhibitors and the Risk of Severe Urinary Tract Infection - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-02-15","captureTimestamp":"2026-02-15T15:46:48.378000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/54001.html","snippet":"DSEN Abstract SGLT2 Inhibitors and the Risk of Severe Urinary Tract Infection A study conducted by the Canadian Network for Observational Drug Effect Studies (CNODES) SGLT2 inhibitor use was not associated with an increased risk of severe UTI compared to use of DPP-4 inhibitors…","rawSnapshotUrl":"/api/snapshots/raw/1209381","browseUrl":"https://replay.healtharchive.ca/job-8/20260215154648/https://cihr-irsc.gc.ca/e/54001.html#ha_snapshot=1209381","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}